Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mitchell R. Smith, MD, PhD
Fox Chase Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
418 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Moncton Hospital
Moncton, New Brunswick, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Kaiser Permanente, Fremont
Fremont, California, United States
- Kaiser Permanente
Fresno, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Kaiser Permanente-Redwood City
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Kaiser Permanente - Sacramento
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Kaiser Permanente San Leandro
San Leandro, California, United States
- Kaiser Permanente-San Rafael
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Kaiser Permanente-Santa Rosa
Santa Rosa, California, United States
- Kaiser Permanente-South San Francisco
South San Francisco, California, United States
- Stanford University Hospitals and Clinics
Stanford, California, United States
- Kaiser Permanente-Stockton
Stockton, California, United States
- Kaiser Permanente Medical Center-Vacaville
Vacaville, California, United States
- Kaiser Permanente-Vallejo
Vallejo, California, United States
- Kaiser Permanente-Walnut Creek
Walnut Creek, California, United States
- Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Colorado Cancer Research Program Ccop
Denver, Colorado, United States
- Exempla Saint Joseph Hospital
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Aug 2012
- Primary completion
- 25 Feb 2023
- Completion
- 30 Sept 2031
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 373
- Registry id
- NCT01415752
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.